Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Anticancer Research|August 30, 2008
Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cellsDoreen Kunze, Daniela Wuttig, Susanne Fuessel, et al.
International Journal of Oncology|June 7, 2003
Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCRSusanne Fuessel, Denise Sickert, Axel Meye, et al.
The Prostate|August 22, 2006
Quantitative multi-gene expression profiling of primary prostate cancerUta Schmidt, Susanne Fuessel, Rainer Koch, et al.
Clinical Biochemistry|December 12, 2018
Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancerSebastian Stasik, Karsten Salomo, Ulrike Heberling, et al.
International Journal of Cancer|June 11, 2015
Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybridsArturo Castro Nava, Monica Cojoc, Claudia Peitzsch, et al.
International Journal of Molecular Medicine|May 13, 2004
Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinomaChristian Hoefling, Hannelore Schmidt, Matthias Meinhardt, et al.
International Journal of Pharmaceutics|January 18, 2015
Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancerChristiane Rieger, David Kunhardt, Anika Kaufmann, et al.
Journal of Cancer Research and Clinical Oncology|September 3, 2015
Diagnostic and prognostic value of bladder cancer-related transcript markers in urineJuliane Schmidt, Catharina Propping, Woei-Yun Siow, et al.
International Journal of Cancer|April 25, 2009
Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patientDaniela Wuttig, Barbara Baier, Susanne Fuessel, et al.
Pageof 9